The purpose of the Administrative Core is (1) to provide overall direction and provide fiscal management for the Indiana Alzheimer Disease Center (IADC), (2) to coordinate and integrate the activities of the IADC components, (3) to encourage research into Alzheimer disease (AD) and related disorders by the faculty at Indiana University School of Medicine and (4) to encourage, evaluate, support and supervise the conduct of the pilot project. The Core Leader is Dr. Bernardino Ghetti. He will be assisted by an Associate Co-Director Dr. Martin R. Farlow. One of the IADC missions is that of nurturing new research in AD and related dementias and of encouraging new investigators to develop research interests in areas of AD. Two pilot projects will be available annually through the IADC. Junior investigators from Indiana University are encouraged to apply. A call for research proposals will be made annually to all chairpersons and directors of centers, institutes and divisions within Indiana University and Purdue University as well as other selected institutions that do not have an Alzheimer disease center.
It is estimated that as many as 5 million Americans have AD. The Indiana Alzheimer Disease Center provides an environment and resources directed towards fostering and coordinating research and educational activities on AD and other dementing illnesses.
|Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355|
|Ridge, Perry G; Wadsworth, Mark E; Miller, Justin B et al. (2018) Assembly of 809 whole mitochondrial genomes with clinical, imaging, and fluid biomarker phenotyping. Alzheimers Dement 14:514-519|
|Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25|
|Di Fede, Giuseppe; Catania, Marcella; Maderna, Emanuela et al. (2018) Molecular subtypes of Alzheimer's disease. Sci Rep 8:3269|
|Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169|
|Konar, Arpita; Kumar, Ashish; Maloney, Bryan et al. (2018) A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling. Sci Rep 8:9928|
|Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104|
|Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161|
|Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325|
|Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487|
Showing the most recent 10 out of 604 publications